Literature DB >> 24277673

Changing epidemiology of metabolic syndrome and type 2 diabetes in Chinese youth.

JunFen Fu1, Heranmaye C Prasad.   

Abstract

China is gradually taking its place as one of the world's economic giants and concurrently learning to understand how to bear the burdens of diseases that are more common in the fully developed world, such as pediatric obesity, metabolic syndrome, and type 2 diabetes mellitus. The purpose of this review is to consolidate the available information regarding these and draw the focus toward their sequential progression and increasing prevalence in Chinese children. Studies were collected in both English and Chinese, and the data were reviewed on the basis of disease prevalence and risk factors that are known from scientific literature that has been published to date. The majority of studies with appropriate content for inclusion here have been conducted within the last 15 years and up to date information from recent local and international research has also been included. Several factors have been implicated for the rise in obesity, most notably, the progressing economic expansion and exposure of local Chinese populations to Western influences. With this, metabolic syndrome has become a growing concern, as it is a precursor to cardiovascular disease and type 2 diabetes, leading to the alarmingly rapid development of deleterious consequences in children. The International Diabetes Federation proposed a definition for metabolic syndrome in 2007 (MS-IDF2007) worldwide, but whether it is also suitable for the Chinese population remains uncertain, so we have created the Chinese definition of metabolic syndrome upon the IDF framework. This MS-CHN2012 definition is based on multicenter studies to simplify and standardize primary care screening methods and is the first of its kind in China. Juvenile type 2 diabetes is the most worrisome result of obesity and metabolic syndrome, and studies have shown that the prevalence has doubled within 5 years-surpassing the prevalence of juvenile type 1 diabetes. Because of the extremely low number of studies currently published on these topics in China, emphasis needs to be placed on the assessment of the health status of the population. Screening methods are imperative because lifestyle interventions can reduce and even reverse the pathologic consequences of this disease, if detected early.

Entities:  

Mesh:

Year:  2014        PMID: 24277673     DOI: 10.1007/s11892-013-0447-z

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN: 1534-4827            Impact factor:   4.810


  36 in total

1.  Screening for type 2 diabetes.

Authors: 
Journal:  Diabetes Care       Date:  2003-01       Impact factor: 19.112

2.  [The prevalence of type 2 diabetes mellitus and prediabetes in children].

Authors:  Yan-Yan Jin; Li Liang; Jun-Fen Fu; Xiu-Min Wang
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2011-02

3.  Prevalence of the metabolic syndrome in Zhejiang Chinese obese children and adolescents and the effect of metformin combined with lifestyle intervention.

Authors:  J-F Fu; L Liang; C-C Zou; F Hong; C-L Wang; X-M Wang; Z-Y Zhao
Journal:  Int J Obes (Lond)       Date:  2006-09-05       Impact factor: 5.095

Review 4.  Indices of abdominal obesity are better discriminators of cardiovascular risk factors than BMI: a meta-analysis.

Authors:  Crystal Man Ying Lee; Rachel R Huxley; Rachel P Wildman; Mark Woodward
Journal:  J Clin Epidemiol       Date:  2008-03-21       Impact factor: 6.437

5.  [Study on physique index set for Chinese children and adolescents].

Authors:  Xue-feng Chen; Li Liang; Jun-fen Fu; Chun-xiu Gong; Feng Xiong; Ge-li Liu; Fei-hong Luo; Shao-ke Chen
Journal:  Zhonghua Liu Xing Bing Xue Za Zhi       Date:  2012-05

Review 6.  An epidemiological overview of diabetes across the world.

Authors:  Danny Meetoo; Peter McGovern; Reema Safadi
Journal:  Br J Nurs       Date:  2007 Sep 13-27

7.  Prevalence of the metabolic syndrome in Chinese adolescents.

Authors:  Y Li; X Yang; F Zhai; F J Kok; W Zhao; J Piao; J Zhang; Z Cui; G Ma
Journal:  Br J Nutr       Date:  2007-07-30       Impact factor: 3.718

Review 8.  Overview of obesity in Mainland China.

Authors:  C M Chen
Journal:  Obes Rev       Date:  2008-03       Impact factor: 9.213

9.  Prevalence and association between obesity and metabolic syndrome among Chinese elementary school children: a school-based survey.

Authors:  WeiJia Liu; Rong Lin; AiLing Liu; Lin Du; Qing Chen
Journal:  BMC Public Health       Date:  2010-12-22       Impact factor: 3.295

10.  Waist circumference, waist-hip ratio and waist-height ratio percentiles and central obesity among Pakistani children aged five to twelve years.

Authors:  Muhammad Umair Mushtaq; Sibgha Gull; Hussain Muhammad Abdullah; Ubeera Shahid; Mushtaq Ahmad Shad; Javed Akram
Journal:  BMC Pediatr       Date:  2011-11-21       Impact factor: 2.125

View more
  14 in total

1.  Distinct temporal phases of microvascular rarefaction in skeletal muscle of obese Zucker rats.

Authors:  Jefferson C Frisbee; Adam G Goodwill; Stephanie J Frisbee; Joshua T Butcher; Robert W Brock; I Mark Olfert; Evan R DeVallance; Paul D Chantler
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-10-10       Impact factor: 4.733

Review 2.  Sex differences in the burden of type 2 diabetes and cardiovascular risk across the life course.

Authors:  Amy G Huebschmann; Rachel R Huxley; Wendy M Kohrt; Philip Zeitler; Judith G Regensteiner; Jane E B Reusch
Journal:  Diabetologia       Date:  2019-08-27       Impact factor: 10.122

Review 3.  Global aetiology and epidemiology of type 2 diabetes mellitus and its complications.

Authors:  Yan Zheng; Sylvia H Ley; Frank B Hu
Journal:  Nat Rev Endocrinol       Date:  2017-12-08       Impact factor: 43.330

4.  Rutaecarpine ameliorates hyperlipidemia and hyperglycemia in fat-fed, streptozotocin-treated rats via regulating the IRS-1/PI3K/Akt and AMPK/ACC2 signaling pathways.

Authors:  Xu-qiang Nie; Huai-hong Chen; Jian-yong Zhang; Yu-jing Zhang; Jian-wen Yang; Hui-jun Pan; Wen-xia Song; Ferid Murad; Yu-qi He; Ka Bian
Journal:  Acta Pharmacol Sin       Date:  2016-03-14       Impact factor: 6.150

5.  Combined Association of Diet and Cardiorespiratory Fitness with Metabolic Syndrome in Chinese Schoolchildren.

Authors:  Wei Liao; Dian-Ming Xiao; Yao Huang; Hong-Jie Yu; Shuai Yuan; Tao Chen; Philayrath Phongsavan; Zong-Fu Mao; Qi-Qiang He
Journal:  Matern Child Health J       Date:  2016-09

6.  Can Myogenic Tone Protect Endothelial Function? Integrating Myogenic Activation and Dilator Reactivity for Cerebral Resistance Arteries in Metabolic Disease.

Authors:  Brayden D Halvorson; John J McGuire; Krishna K Singh; Joshua T Butcher; Julian H Lombard; Paul D Chantler; Jefferson C Frisbee
Journal:  J Vasc Res       Date:  2021-05-10       Impact factor: 1.934

7.  Efficacy of supplementary vitamin D on improvement of glycemic parameters in patients with type 2 diabetes mellitus; a randomized double blind clinical trial.

Authors:  Hamid Nasri; Saeed Behradmanesh; Ahmad Reza Maghsoudi; Ali Ahmadi; Parto Nasri; Mahmoud Rafieian-Kopaei
Journal:  J Renal Inj Prev       Date:  2013-11-30

8.  TriGlycerides and high-density lipoprotein cholesterol ratio compared with homeostasis model assessment insulin resistance indexes in screening for metabolic syndrome in the chinese obese children: a cross section study.

Authors:  Jianfeng Liang; Junfen Fu; Youyun Jiang; Guanping Dong; Xiumin Wang; Wei Wu
Journal:  BMC Pediatr       Date:  2015-09-28       Impact factor: 2.125

9.  Translational medicine as a new clinical tool and application which improves metabolic diseases: perspectives from 2012 Sino-American symposium on clinical and translational medicine.

Authors:  Lin Shi; Elena López Villar; Chengshui Chen
Journal:  Clin Transl Med       Date:  2014-02-10

10.  The Impacts of Obesity and Metabolic Abnormality on Carotid Intima-Media Thickness and Non-Alcoholic Fatty Liver Disease in Children from an Inland Chinese City.

Authors:  Xiao-Yue Wang; Xiang-Hua Zhang; Chao Hua Yao; Hong-Hui Zhu; Liang Zhang
Journal:  J Clin Med       Date:  2014-03-20       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.